Zepp Health Corp ADR (ZEPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,808 | -31,086 | -41,901 | 21,490 | 35,204 |
| Depreciation Amortization | 5,017 | 7,690 | 8,498 | 8,142 | 4,158 |
| Income taxes - deferred | 13,445 | -2,876 | -9,456 | -2,933 | -1,600 |
| Accounts receivable | -5,082 | 36,384 | -21,120 | -37,639 | -20,110 |
| Accounts payable and accrued liabilities | 14,811 | -27,816 | -132,036 | -105,644 | -1,496 |
| Other Working Capital | 7,663 | 47,875 | -81,743 | -82,362 | -32,181 |
| Other Operating Activity | 15,562 | 12,431 | 163,559 | 162,473 | 40,132 |
| Operating Cash Flow | $-24,392 | $42,602 | $-114,199 | $-36,473 | $24,107 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 275 | 1,263 | -1,792 | N/A | N/A |
| PPE Investments | -707 | 6 | -1,180 | -6,832 | -12,805 |
| Net Acquisitions | N/A | 427 | N/A | 3,138 | -4,094 |
| Purchase Of Investment | -6,998 | -282 | -1,846 | -169,128 | -45,100 |
| Sale Of Investment | 4,886 | 4,666 | 1,137 | 3,923 | 30,554 |
| Purchase Sale Intangibles | 965 | 3,051 | -258 | -1,103 | -187 |
| Other Investing Activity | 965 | 1,647 | -2,446 | 1,103 | -260 |
| Investing Cash Flow | $-1,579 | $7,727 | $-6,127 | $-167,796 | $-31,705 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,959 | 56,490 | 121,623 | 231,235 | 185,102 |
| Debt Issued | 5,105 | 8,074 | 44,984 | N/A | N/A |
| Debt Repayment | N/A | 329 | -5,683 | 6,151 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 858 | N/A |
| Common Stock Repurchased | -2,278 | -2,518 | -7,716 | -2,160 | N/A |
| Dividend Paid | N/A | N/A | -5,802 | N/A | N/A |
| Other Financing Activity | -13,309 | -104,051 | -105,478 | -149,607 | -98,563 |
| Financing Cash Flow | $477 | $-41,676 | $41,928 | $86,477 | $86,539 |
| Exchange Rate Effect | -4,240 | -9,305 | 656 | -2,442 | -6,641 |
| Beginning Cash Position | 140,469 | 141,121 | 218,863 | 357,115 | 276,474 |
| End Cash Position | 110,735 | 140,469 | 141,121 | 236,880 | 348,774 |
| Net Cash Flow | $-29,734 | $-652 | $-77,742 | $-120,235 | $72,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,392 | 42,602 | -114,199 | -36,473 | 24,107 |
| Capital Expenditure | -1,403 | -1,596 | -1,180 | -7,227 | -12,805 |
| Free Cash Flow | -25,795 | 41,006 | -115,379 | -43,700 | 11,302 |